Kathy-ann Secker

Otfried Mueller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity.

Journal: Journal for immunotherapy of cancer

Published: December 21, 2023

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.

Journal: Haematologica

Published: July 22, 2020

Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations.

Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations.

Journal: Cancers

Published: April 15, 2020

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.

Journal: Cancers

Published: March 24, 2020

Inhibition of effector B cells by ibrutinib in systemic sclerosis.

Inhibition of effector B cells by ibrutinib in systemic sclerosis.

Journal: Arthritis research & therapy

Published: January 20, 2020

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner.

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner.

Journal: Frontiers in immunology

Published: March 06, 2019

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.

Journal: Arthritis research & therapy

Published: October 30, 2018

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.

Journal: Oncogene

Published: October 04, 2018

Chromobodies to Quantify Changes of Endogenous Protein Concentration in Living Cells.

Chromobodies to Quantify Changes of Endogenous Protein Concentration in Living Cells.

Journal: Molecular & cellular proteomics : MCP

Published: June 12, 2018

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia.

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia.

Journal: Frontiers in immunology

Published: April 06, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026